◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › N › NEOG

Neogen Corporation (NEOG) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-09-02

Neogen Corporation (NEOG) operates in the MEDICAL DEVICES industry and is headquartered in Lansing, United States with about 2,636 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2026-05-31, NEOG reported $870M in revenue and ($8M) in net income.

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments.

Interactive charts & full statements → Open the NEOG valuation workbench →

NEOG Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-05-31	2026-05-31	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31	2020-05-31	2019-05-31	2018-05-31	2017-05-31	2016-05-31	2015-05-31	2014-05-31	2013-05-31	2012-05-31	2011-05-31	2010-05-31	2009-05-31	2008-05-31	2007-05-31
Total Revenue	$870M	$870M	$895M	$924M	$822M	$527M	$468M	$418M	$414M	$402M	$362M	$321M	$283M	$247M	$208M	$184M	$173M	$141M	$119M	$102M	$86M
Gross Profit	$408M	$408M	$421M	$463M	$406M	$243M	$215M	$196M	$192M	$190M	$172M	$153M	$140M	$123M	$109M	$92M	$88M	$73M	$59M	$53M	$45M
Gross Margin %	46.9%	46.9%	47.1%	50.1%	49.4%	46.1%	45.9%	46.9%	46.3%	47.3%	47.6%	47.6%	49.4%	49.5%	52.8%	50.2%	50.8%	51.9%	50.1%	52.0%	51.7%
Operating Income (EBIT)	($22M)	($22M)	$9M	$77M	$38M	$59M	$74M	$68M	$68M	$70M	$65M	$56M	$53M	$43M	$41M	$34M	$36M	$27M	$20M	$18M	$14M
Operating Margin %	-2.5%	-2.5%	1.1%	8.4%	4.6%	11.1%	15.8%	16.2%	16.4%	17.4%	18.0%	17.5%	18.8%	17.5%	19.6%	18.3%	20.8%	19.1%	17.3%	17.6%	15.7%
Net Income	($8M)	($8M)	($1.1B)	($9M)	($23M)	$48M	$61M	$59M	$60M	$63M	$44M	$37M	$34M	$28M	$27M	$23M	$23M	$18M	$14M	$12M	$9M
Net Margin %	-0.9%	-0.9%	-122.1%	-1.0%	-2.8%	9.2%	13.0%	14.2%	14.5%	15.7%	12.1%	11.4%	11.8%	11.4%	13.1%	12.2%	13.2%	12.5%	11.7%	11.8%	10.6%
EBITDA	$172M	$170M	($938M)	$183M	$126M	$84M	$96M	$91M	$91M	$87M	$80M	$69M	$64M	$53M	$48M	$40M	$41M	$32M	$26M	$22M	$17M
Earnings Per Share (EPS)	$-0.04	$-0.04	$-5.03	$-0.04	$-0.12	$0.45	$0.57	$0.56	$0.57	$0.60	$0.43	$0.36	$0.34	$0.28	$0.28	$0.23	$0.24	$0.19	$0.15	$0.13	$0.11
Shares Outstanding (M)	218M	218M	217M	216M	189M	108M	107M	106M	105M	104M	102M	101M	100M	99M	97M	96M	95M	92M	90M	90M	85M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NEOG Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-05-31	2026-02-28	2025-11-30	2025-08-31	2025-05-31	2025-02-28	2024-11-30	2024-08-31
Total Revenue	$225M	$211M	$225M	$209M	$225M	$221M	$231M	$217M
Gross Profit	$108M	$99M	$107M	$95M	$93M	$87M	$90M	$86M
Gross Margin %	47.9%	46.9%	47.5%	45.4%	41.2%	39.4%	38.8%	39.8%
Operating Income (EBIT)	$3M	($3M)	($5M)	($16M)	($13M)	$12M	$17M	$9M
Operating Margin %	1.4%	-1.6%	-2.4%	-7.7%	-5.9%	5.4%	7.4%	4.0%
Net Income	($11M)	($17M)	($16M)	$36M	($612M)	($11M)	($456M)	($13M)
Net Margin %	-5.0%	-8.1%	-7.1%	17.4%	-271.5%	-5.0%	-197.3%	-5.8%
EBITDA	$37M	$23M	$23M	$89M	($584M)	$37M	($428M)	$33M
Earnings Per Share (EPS)	$-0.05	$-0.08	$-0.07	$0.17	$-2.82	$-0.05	$-2.10	$-0.06
Shares Outstanding (M)	218M	218M	217M	217M	217M	217M	217M	217M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NEOG Free Cash Flow History

Cash flow	TTM → 2026-05-31	2026-05-31	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31	2020-05-31	2019-05-31	2018-05-31	2017-05-31	2016-05-31	2015-05-31	2014-05-31	2013-05-31	2012-05-31	2011-05-31	2010-05-31	2009-05-31	2008-05-31	2007-05-31
Cash from Operations (CFO)	$83M	$83M	$58M	$35M	$41M	$68M	$81M	$86M	$64M	$69M	$60M	$35M	$44M	$22M	$27M	$22M	$29M	$28M	$11M	$8M	$10M
Capital Expenditures (CapEx)	$99M	$51M	$105M	$111M	$66M	$24M	$27M	$24M	$15M	$21M	$15M	$14M	$10M	$12M	$9M	$12M	$8M	$5M	$3M	$2M	$5M
Free Cash Flow (FCF)	($16M)	$32M	($46M)	($76M)	($25M)	$44M	$54M	$62M	$49M	$48M	$46M	$21M	$34M	$10M	$18M	$10M	$21M	$23M	$8M	$5M	$5M
FCF Margin %	-1.8%	3.7%	-5.2%	-8.2%	-3.0%	8.3%	11.6%	14.8%	11.9%	12.0%	12.6%	6.6%	12.1%	4.1%	8.5%	5.4%	12.2%	16.1%	6.9%	5.3%	6.3%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NEOG Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-05-31	2026-02-28	2025-11-30	2025-08-31	2025-05-31	2025-02-28	2024-11-30	2024-08-31
Cash from Operations (CFO)	$30M	$23M	$19M	$11M	$17M	$19M	$40M	($18M)
Capital Expenditures (CapEx)	$40M	$12M	$24M	$24M	$16M	$33M	$17M	$38M
Free Cash Flow (FCF)	($9M)	$11M	($5M)	($13M)	$0M	($14M)	$23M	($56M)
FCF Margin %	-4.2%	5.2%	-2.0%	-6.3%	0.2%	-6.1%	10.0%	-26.0%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NEOG Balance Sheet History

Balance sheet	2026-05-31	2026-05-31	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31	2020-05-31	2019-05-31	2018-05-31	2017-05-31	2016-05-31	2015-05-31	2014-05-31	2013-05-31	2012-05-31	2011-05-31	2010-05-31	2009-05-31	2008-05-31	2007-05-31
Total Assets	$3.3B	$3.3B	$3.4B	$4.5B	$4.6B	$993M	$920M	$797M	$696M	$618M	$528M	$452M	$392M	$345M	$289M	$252M	$220M	$180M	$142M	$126M	$105M
Cash & Cash Equivalents	$186M	$186M	$129M	$171M	$163M	$44M	$76M	$66M	$42M	$83M	$78M	$55M	$114M	$41M	$50M	$49M	$36M	$23M	$14M	$14M	$13M
Total Liabilities	$1.3B	$1.3B	$1.4B	$1.4B	$1.4B	$106M	$80M	$72M	$58M	$58M	$57M	$48M	$41M	$39M	$31M	$33M	$31M	$27M	$13M	$15M	$13M
Total Debt (Short + Long-Term)	$794M	$794M	$902M	$898M	$889M	$3M	$1M	$1M	$0M	$0M	$0M	$2M	$4M	$2M	$2M	$3M	$0M	$0M	$0M	$0M	$0M
Total Shareholders' Equity	$2.1B	$2.1B	$2.1B	$3.1B	$3.1B	$887M	$840M	$725M	$638M	$560M	$472M	$404M	$351M	$306M	$258M	$219M	$189M	$153M	$129M	$111M	$92M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NEOG viewer.

Other Companies in MEDICAL DEVICES

ITGR · Integer Holdings Corp — $4 billion
LIVN · LivaNova PLC — $4 billion
IRTC · iRhythm Technologies Inc — $4 billion
TMDX · TransMedics Group Inc — $3 billion
AXGN · Axogen Inc — $3 billion
ALMR · Alamar Biosciences, Inc. Common Stock — $2 billion
INSP · Inspire Medical Systems Inc — $2 billion
UFPT · UFP Technologies Inc — $2 billion

← NEO All “N” companies NEOGEN →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.